InvestorsHub Logo
Followers 130
Posts 14996
Boards Moderated 1
Alias Born 06/04/2018

Re: None

Friday, 05/31/2019 2:50:43 PM

Friday, May 31, 2019 2:50:43 PM

Post# of 42488
News: $HGEN Kite and Humanigen Announce Clinical Collaboration to Evaluate Investigational Combination of Yescarta® (axicabtagene ciloleucel) With lenzilumab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma

SANTA MONICA, Calif. and BURLINGAME, Calif., May 31, 2019 (GLOBE NEWSWIRE) -- Kite, a Gilead Company (Nasdaq: GILD) and Humanigen, Inc., (HGEN) announced today the formation of a clinical collaboration to conduct a Phase 1/2 study of lenzilumab, an investigational anti-GM-CSF monoclonal ant...

Got this from https://marketwirenews.com/news-releases/kite-and-humanigen-announce-clinical-collaboration-to-evaluate-investigational-combination-of-yescarta-xae-axicabtagene-ciloleucel-with-lenzilumab-in-relapsed-refractory-diffuse-large-b-cell-lymphoma-8277290.html